Tag: Polar Capital
Pfizer keeping tabs on AstraZeneca for potential $100 billion deal
US drug-maker Pfizer Inc has prepared a third offer to acquire Britain's AstraZeneca Plc, after refusing Pfizer’s earlier approaches for a takeover.
According to the...
Featured Article
Why manufacturers are embracing AI-powered smart supply chains
Manufacturers are facing an increasingly volatile environment, where rapid changes in demand, supply chain disruptions, and continued cost pressures are transforming the way products are planned, made, and delivered.
